A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

Adults with type 1 diabetes had a greater reduction in HbA1c and improvement in time in range with semaglutide than placebo. ... (Ozempic, Novo Nordisk) or placebo. Viral N. Shah.

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...

A phase 3 teplizumab trial, of two 12-day courses or placebo given to 328 young people with new-onset type 1 diabetes, was also published in the December 7, 2023, issue of NEJM.That study appeared ...

FDA approves 1st automated, tubeless insulin pump for people with Type 1 diabetes. The Omnipod 5 will be immediately available for people ages 6 to 70. By Katie Kindelan. January 28, 2022, 6:25 AM.

Edelman also provided other tips for managing common type 1 diabetes challenges, including reducing post-meal glucose spikes by bolusing at least 20-30 minutes prior to eating or using the fast ...